![]() |
|
|
Molecular Pharmacology, Vol 16, 147-153, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics
1 Afdelingen Farmacognosie, Fytochemie en Toxicologie, Pathologische Biochemie en Chemie der Proteïnen,
Faculteit Geneeskunde en Farmacie en Institut voor Molekulaire Biologie, Vrije Universiteit Brussel,
Paardentraat 67, B-1640 Sint-Genesius-Rode
The binding of phenylbutazone to human serum albumin was investigated by UV
difference-spectroscopy. From these measurements at two different wavelengths an
association constant of 6.5 x 105 M-1 at 27.5° was calculated. The intrinsic tryptophan
fluorescence of human serum albumin was quenched by binding of phenylbutazone. This
quenching was not due to absorption or nonradiative energy transfer, but to a direct
perturbation of the molecular environment of the fluorophore. Fluorescence measurements allowed us to calculate the binding parameters of the phenylbutazone-albumin
interaction and to evaluate the thermodynamics of the binding. The association constant
varied from 6.2 to 9.5 x 105 M-1 at temperatures from 18° to 45° corresponding with free
energy changes from -7.7 to -8.7 kcal/mole. The reaction is endothermic (
H = +3.0
kcal/mole) and strongly entropy-driven (
S = +36.8 e.u.). This is characteristic for a
hydrophobic interaction with solvent perturbation. Spectrophotometric and fluorescence
measurements both suggested that upon binding, phenylbutazone forms a
-
complex
with the tryptophan residue of the protein. This points toward the presence of that
residue in the high affinity binding site. Yet the alternative hypothesis of a conformational
change in the protein causing the optical changes could not be definitely excluded.